Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.42 USD | -3.64% | -5.01% | -1.17% |
May. 31 | Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.17% | 525M | |
+15.39% | 121B | |
+13.45% | 107B | |
-5.29% | 24.82B | |
+1.63% | 22.48B | |
-10.09% | 18.32B | |
-42.28% | 16.33B | |
-15.85% | 15.31B | |
+3.35% | 14.08B | |
+24.33% | 11.74B |
- Stock Market
- Equities
- CELC Stock
- News Celcuity Inc.
- Celcuity's Breast Cancer Therapy Gedatolisib Gets FDA's Breakthrough Designation